What is the first-line therapy for an 80-year-old patient with constipation?

First-Line Treatment for Elderly Patients with Constipation

Polyethylene glycol (PEG) at 17 g/day is the number one treatment for elderly patients with constipation, offering the best combination of efficacy, tolerability, and safety profile in this population 1.

Why PEG is the Preferred Choice

The ESMO guidelines specifically highlight that PEG offers an efficacious and tolerable solution for elderly patients with a good safety profile 1. This recommendation is particularly important because elderly patients have unique physiological constraints that make other laxatives less suitable or potentially dangerous.

Critical Safety Considerations in the Elderly

Before initiating PEG, you must individualize treatment based on the patient's medical history, particularly:

• Cardiac comorbidities: Monitor for dehydration and electrolyte imbalances, especially if the patient is on diuretics or cardiac glycosides 1
• Renal function: Avoid magnesium-based laxatives (magnesium hydroxide, magnesium sulfate) if creatinine clearance is impaired, as hypermagnesemia risk increases significantly 1, 2
• Mobility status: Avoid bulk-forming laxatives (psyllium, methylcellulose) in non-ambulatory patients with low fluid intake due to mechanical obstruction risk 1
• Swallowing disorders: Avoid liquid paraffin in bed-bound patients or those with dysphagia due to aspiration lipoid pneumonia risk 1

Treatment Algorithm for Elderly Constipation

Step 1: Non-Pharmacological Measures (Always Start Here)

Before prescribing any laxative, implement these foundational strategies 1:

• Ensure toilet access, especially for patients with decreased mobility
• Optimize toileting routine: Attempt defecation twice daily, 30 minutes after meals, strain no more than 5 minutes
• Positioning: Use a small footstool to assist gravity and facilitate easier straining
• Increase fluid intake within patient's cardiac and renal limits
• Increase activity/mobility even if just bed-to-chair transfers
• Dietetic support: Address anorexia of aging and chewing difficulties that reduce stool volume

Step 2: First-Line Pharmacological Treatment

Start with PEG 17 g/day 1. This osmotic laxative creates an osmotic gradient that draws water into the colon without requiring increased fluid intake like bulk-forming agents do—a critical advantage in elderly patients who often have difficulty maintaining adequate hydration 3.

Step 3: Alternative Osmotic Laxatives (If PEG Unavailable or Not Tolerated)

If PEG is not available or tolerated, consider:

• Magnesium oxide (MgO): 500 mg to 1.5 g/day, but only if creatinine clearance >20 mg/dL 2. While studied primarily in Japanese populations, it offers low cost and OTC availability
• Lactulose: 15-30 mL daily, though bloating and flatulence are common and dose-dependent, which may limit tolerability 2

Step 4: Stimulant Laxatives (For Intermittent Use Only)

Stimulant laxatives (senna, bisacodyl, sodium picosulfate) should be used only as needed, not for chronic daily use 1, 4. They can cause abdominal pain and cramping, particularly problematic in elderly patients 1.

Step 5: Rectal Interventions (For Specific Situations)

Suppositories and enemas are first-line therapy when digital rectal examination identifies a full rectum or fecal impaction 1. Use isotonic saline enemas rather than sodium phosphate enemas in elderly patients due to better safety profile 1.

Contraindications to enemas include: neutropenia, thrombocytopenia, paralytic ileus, recent colorectal/gynecological surgery, recent anal trauma, severe colitis, toxic megacolon, undiagnosed abdominal pain, or recent pelvic radiotherapy 1.

What NOT to Use in Elderly Patients

Several commonly available laxatives should be avoided in elderly patients:

• Bulk-forming laxatives (psyllium, calcium polycarbophil): Require increased fluid intake and pose mechanical obstruction risk in non-ambulatory patients 1
• Liquid paraffin: Aspiration pneumonia risk in bed-bound or dysphagic patients 1
• Magnesium-based laxatives: Hypermagnesemia risk, especially with renal impairment 1

Evidence Quality and Limitations

The evidence supporting PEG in elderly patients comes primarily from expert consensus and clinical experience (Level V evidence) 1, though systematic reviews support its effectiveness and safety in longer-term use up to 6 months 3. The ESMO guidelines, while focused on cancer patients, provide the most specific and detailed recommendations for elderly constipation management available in current literature.

The AGA-ACG guidelines support MgO as an attractive first-line option for chronic idiopathic constipation due to efficacy, tolerability, OTC availability, and low cost 2, though this recommendation is based on trials conducted exclusively in Japan with limited long-term safety data.

Common Pitfalls to Avoid

1. Don't prescribe bulk-forming laxatives as first-line in elderly patients—they require increased fluid intake that many elderly patients cannot maintain
2. Don't use magnesium-based laxatives without checking renal function first
3. Don't forget to monitor patients on diuretics or cardiac glycosides for dehydration and electrolyte disturbances when starting any laxative
4. Don't overlook fecal impaction—perform digital rectal examination if suspected, as this requires different management (disimpaction followed by maintenance regimen) 1